List of Tables
Table 1. Giant Cell Arteritis Treatment Market Trends
Table 2. Giant Cell Arteritis Treatment Market Drivers & Opportunity
Table 3. Giant Cell Arteritis Treatment Market Challenges
Table 4. Giant Cell Arteritis Treatment Market Restraints
Table 5. Global Giant Cell Arteritis Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Giant Cell Arteritis Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Giant Cell Arteritis Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Giant Cell Arteritis Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Giant Cell Arteritis Treatment
Table 10. Global Giant Cell Arteritis Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Giant Cell Arteritis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Giant Cell Arteritis Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Giant Cell Arteritis Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Giant Cell Arteritis Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Giant Cell Arteritis Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Giant Cell Arteritis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Giant Cell Arteritis Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Giant Cell Arteritis Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Giant Cell Arteritis Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Giant Cell Arteritis Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Giant Cell Arteritis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Giant Cell Arteritis Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Giant Cell Arteritis Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Giant Cell Arteritis Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Giant Cell Arteritis Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Giant Cell Arteritis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Giant Cell Arteritis Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Giant Cell Arteritis Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Johns Hopkins Hospital Basic Information List
Table 32. Johns Hopkins Hospital Description and Business Overview
Table 33. Johns Hopkins Hospital Giant Cell Arteritis Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of Johns Hopkins Hospital (2019-2024)
Table 35. Johns Hopkins Hospital Recent Developments
Table 36. Fortis Healthcare Basic Information List
Table 37. Fortis Healthcare Description and Business Overview
Table 38. Fortis Healthcare Giant Cell Arteritis Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of Fortis Healthcare (2019-2024)
Table 40. Fortis Healthcare Recent Developments
Table 41. American College of Rheumatology Basic Information List
Table 42. American College of Rheumatology Description and Business Overview
Table 43. American College of Rheumatology Giant Cell Arteritis Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of American College of Rheumatology (2019-2024)
Table 45. American College of Rheumatology Recent Developments
Table 46. Duke University Health System Basic Information List
Table 47. Duke University Health System Description and Business Overview
Table 48. Duke University Health System Giant Cell Arteritis Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of Duke University Health System (2019-2024)
Table 50. Duke University Health System Recent Developments
Table 51. Lahey Clinic Foundation Basic Information List
Table 52. Lahey Clinic Foundation Description and Business Overview
Table 53. Lahey Clinic Foundation Giant Cell Arteritis Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of Lahey Clinic Foundation (2019-2024)
Table 55. Lahey Clinic Foundation Recent Developments
Table 56. Key Raw Materials Lists
Table 57. Raw Materials Key Suppliers Lists
Table 58. Giant Cell Arteritis Treatment Downstream Customers
Table 59. Giant Cell Arteritis Treatment Distributors List
Table 60. Research Programs/Design for This Report
Table 61. Key Data Information from Secondary Sources
Table 62. Key Data Information from Primary Sources
Table 63. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Giant Cell Arteritis Treatment Product Picture
Figure 2. Global Giant Cell Arteritis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Giant Cell Arteritis Treatment Report Years Considered
Figure 5. Global Giant Cell Arteritis Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Giant Cell Arteritis Treatment Revenue in 2023
Figure 7. Giant Cell Arteritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Corticosteroid Therapy Picture
Figure 9. Adjuvant Agents Picture
Figure 10. Global Giant Cell Arteritis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Giant Cell Arteritis Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospitals
Figure 13. Product Picture of Clinics
Figure 14. Product Picture of ASCs
Figure 15. Product Picture of Others
Figure 16. Global Giant Cell Arteritis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Giant Cell Arteritis Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Giant Cell Arteritis Treatment Sales Value (%), (2019-2030)
Figure 29. United States Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 35. China Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 37. China Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. India Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. India Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. Giant Cell Arteritis Treatment Industrial Chain
Figure 51. Giant Cell Arteritis Treatment Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
